GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
HIST1H2BH | Histone cluster 1, H2bh | | | | | | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
HOXD12 | Homeobox D12 | Transcription factors
| | | | | Tissue enhanced |
HRASLS2 | HRAS-like suppressor 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
IL17REL | Interleukin 17 receptor E-like | | | | | | Tissue enhanced |
INSL5 | Insulin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
ISL1 | ISL LIM homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
ITLN2 | Intelectin 2 | Predicted secreted proteins
| | | | | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | | | | Group enriched |
KCNE2 | Potassium voltage-gated channel, Isk-related family, member 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
KLK15 | Kallikrein-related peptidase 15 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KRT20 | Keratin 20 | Plasma proteins
| | | | | Group enriched |
LGALS4 | Lectin, galactoside-binding, soluble, 4 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
LGALS9B | Lectin, galactoside-binding, soluble, 9B | | | | | | Tissue enhanced |
LGALS9C | Lectin, galactoside-binding, soluble, 9C | | | | | | Tissue enhanced |
LIPF | Lipase, gastric | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MALRD1 | MAM and LDL receptor class A domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MEP1B | Meprin A, beta | Enzymes Predicted membrane proteins
| | | | | Group enriched |
MGAM | Maltase-glucoamylase (alpha-glucosidase) | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins
| | | | | Tissue enhanced |
MLPH | Melanophilin | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MUC12 | Mucin 12, cell surface associated | Predicted membrane proteins
| | | | | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC17 | Mucin 17, cell surface associated | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC2 | Mucin 2, oligomeric mucus/gel-forming | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MUC4 | Mucin 4, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MUC5AC | Mucin 5AC, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Tissue enriched |
MUC6 | Mucin 6, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Group enriched |
MYO7B | Myosin VIIB | Cytoskeleton related proteins
| | | | | Tissue enhanced |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
NLRP6 | NLR family, pyrin domain containing 6 | Plasma proteins
| | | | | Group enriched |
NOX1 | NADPH oxidase 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
NTS | Neurotensin | Predicted secreted proteins
| | | | | Group enriched |
NXPE1 | Neurexophilin and PC-esterase domain family, member 1 | Predicted membrane proteins
| | | | | Group enriched |
ONECUT2 | One cut homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PADI2 | Peptidyl arginine deiminase, type II | Enzymes
| | | | | Tissue enhanced |